Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B. Kumada T, Toyoda H, Yasuda S, Ito T, et al. Eur J Gastroenterol Hepatol 2021;33.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kumada T, Toyoda H, Yasuda S, Ito T, et al. Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B. Eur J Gastroenterol Hepatol 2021;33.
PMID: 35048656